Gray R, Bradley R, Braybrooke J, et al. Increasing the dose density of adjuvant chemotherapy by shortening intervals between courses or by sequential drug administration significantly reduces both disease recurrence and breast cancer mortality: An EBCTCG meta-analysis of 21,000 women in 16 randomised trials. SABCS 2017, GS1-01.
Avelumab plus axitinib veelbelovend bij type B3-thymoom en thymuscarcinoom
okt 2022 | Immuuntherapie